Capital International Inc. CA Boosts Stake in Illumina

Life sciences company Illumina sees increased investment from Capital International Inc. CA

Published on Mar. 11, 2026

Got story updates? Submit your updates here. ›

Capital International Inc. CA, an investment management firm, has increased its stake in Illumina, Inc. (NASDAQ:ILMN) by 52.3% during the third quarter. The firm now owns 87,136 shares of the life sciences company's stock, worth approximately $8.275 million as of its most recent SEC filing.

Why it matters

Illumina is a leading provider of DNA sequencing systems and related products, playing a key role in the growing field of genomics. The increased investment from a major institutional investor like Capital International Inc. CA suggests confidence in Illumina's long-term growth prospects.

The details

According to the 13F filing, Capital International Inc. CA acquired an additional 29,935 shares of Illumina during the third quarter, bringing its total stake to 87,136 shares. This represents approximately 0.06% ownership of Illumina's outstanding shares. The investment firm cited Illumina's leading position in the life sciences industry and potential for continued innovation and market expansion as reasons for the increased investment.

  • Capital International Inc. CA filed its 13F report for the third quarter of 2026 on March 11, 2026.

The players

Capital International Inc. CA

An investment management firm that has increased its stake in Illumina, Inc.

Illumina, Inc.

A leading life sciences company that develops and markets DNA sequencing systems and related products.

Got photos? Submit your photos here. ›

The takeaway

The increased investment from Capital International Inc. CA in Illumina suggests that the life sciences company is seen as a promising long-term investment by major institutional investors. This could signal continued growth and innovation in the genomics industry, which Illumina is well-positioned to capitalize on.